The purpose is to familiarize the UNICOM partners and impacted stakeholders with the well-established and robust IHE testing and certification process, including the tooling available to support these processes.
The session will have a special focus on the interactions between Regulation and Authorization authorities – industry (representing Development and Production) and medicinal product dictionary providers (representing Dissemination and Information).
IHE Pharmacy is already a well-established domain for the latter two stages in the IDMP landscape: testing for Prescription and Dispensation, as well as for Utilization and Outcome Assessment has been in place for many years. Numerous vendors have, for instance, successfully tested their product’s implementation of the IHE profiles for Pharmacy Prescription (17 vendors) and Pharmacy Dispense (16) and these tests are also used for nationwide implementation in Austria (Medication List operational for several years) and Switzerland, among others.
Preliminary programme:
The UNICOM Innovation Action has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 875299.
